This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Impact on Public Health and Implications for Other Polysaccharide-Based

John B. obbins, MD; Rachel Schneerson, MD; Anders Porter, PhD; David H. Smith, MD

JAMA. 1996;276(14):1181-1185.

Abstract
The development of Haemophilus influenzae type b((Hib)gate vaccines has led to the virtual elimination of systemic infections caused by that pathogen, has provided insights into the pathogenesis of and immunity to other capsulated bacteria, and has contributed to the development of new vaccines. Meningitis, a common and serious infection of children, and other infections caused by Hib have been virtually eliminated in countries that have achieved widespread vaccination with Hib conjugates, including the United States, Canada, the United Kingdom, Iceland, Scandinavia, France, and Germany. Hib conjugates have also been shown to be highly effective in developing countries. The principles derived from use of these vaccines, along with studies of other capsulated pathogens, should allow the rapid inclusion of new polysaccharide-based conjugates into routine vaccination schedules of infants, and should help to realize further reductions in serious systemic infectious diseases.

Author Affiliations
From the National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Md (Drs Robbins and Schneerson); University of Rochester (NY) (Dr Anderson); and David Hamilton Smith Foundation, New York, NY (Dr Smith). Dr Anderson is now retired.

Footnotes
Drs Robbins, Schneerson, Anderson, and Smith are recipients of the 1996 Albert Lasker Clinical Medical Research Award.

Reprints: John B. Robbins, MD, Laboratory of Developmental and Molecular Immunity, National Institute of Child Health and Human Development, National Institutes of Health, Bldg 6, Room 424, 9000 Rockville Pike, Bethesda, MD, 20892-2720.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Important Science--It's All about the SPIN
Casadevall and Fang
Infect. Immun. 2009;77:4177-4180.
ABSTRACT | FULL TEXT  

Extracellular structure of polysialic acid explored by on cell solution NMR
Azurmendi et al.
Proc. Natl. Acad. Sci. USA 2007;104:11557-11561.
ABSTRACT | FULL TEXT  

A Synthetic Conjugate Polysaccharide Vaccine Against Haemophilus influenzae Type b
Verez-Bencomo et al.
Science 2004;305:522-525.
ABSTRACT | FULL TEXT  

Cognitive and Executive Function 12 Years after Childhood Bacterial Meningitis: Effect of Acute Neurologic Complications and Age of Onset
Anderson et al.
J Pediatr Psychol 2004;29:67-81.
ABSTRACT | FULL TEXT  

Antibodies to Keyhole Limpet Hemocyanin Cross-React with an Epitope on the Polysaccharide Capsule of Cryptococcus neoformans and Other Carbohydrates: Implications for Vaccine Development
May et al.
J. Immunol. 2003;171:4905-4912.
ABSTRACT | FULL TEXT  

Persistent Efficacy of Vi Conjugate Vaccine against Typhoid Fever in Young Children
Lanh et al.
NEJM 2003;349:1390-1391.
FULL TEXT  

Preparation and Characterization of Group A Meningococcal Capsular Polysaccharide Conjugates and Evaluation of Their Immunogenicity in Mice
Jin et al.
Infect. Immun. 2003;71:5115-5120.
ABSTRACT | FULL TEXT  

High Affinity Mimotope of the Polysaccharide Capsule of Cryptococcus neoformans Identified from an Evolutionary Phage Peptide Library
Beenhouwer et al.
J. Immunol. 2002;169:6992-6999.
ABSTRACT | FULL TEXT  

Predictors of Bacterial Meningitis in the Era After Haemophilus influenzae
Freedman et al.
Arch Pediatr Adolesc Med 2001;155:1301-1306.
ABSTRACT | FULL TEXT  

Increased Immunogenicity and Induction of Class Switching by Conjugation of Complement C3d to Pneumococcal Serotype 14 Capsular Polysaccharide
Test et al.
Infect. Immun. 2001;69:3031-3040.
ABSTRACT | FULL TEXT  

The Efficacy of a Salmonella typhi Vi Conjugate Vaccine in Two-to-Five-Year-Old Children
Lin et al.
NEJM 2001;344:1263-1269.
ABSTRACT | FULL TEXT  

Evaluation of De-O-Acetylated Meningococcal C Polysaccharide-Tetanus Toxoid Conjugate Vaccine in Infancy: Reactogenicity, Immunogenicity, Immunologic Priming, and Bactericidal Activity against O-Acetylated and De-O-Acetylated Serogroup C Strains
Richmond et al.
Infect. Immun. 2001;69:2378-2382.
ABSTRACT | FULL TEXT  

A Cryptococcal Capsular Polysaccharide Mimotope Prolongs the Survival of Mice with Cryptococcus neoformans Infection
Fleuridor et al.
J. Immunol. 2001;166:1087-1096.
ABSTRACT | FULL TEXT  

Twelve year outcomes following bacterial meningitis: further evidence for persisting effects
Grimwood et al.
Arch. Dis. Child. 2000;83:111-116.
ABSTRACT | FULL TEXT  

Clostridium difficile Recombinant Toxin A Repeating Units as a Carrier Protein for Conjugate Vaccines: Studies of Pneumococcal Type 14, Escherichia coli K1, and Shigella flexneri Type 2a Polysaccharides in Mice
Pavliakova et al.
Infect. Immun. 2000;68:2161-2166.
ABSTRACT | FULL TEXT  

Cognate Stimulatory B-Cell-T-Cell Interactions Are Critical for T-Cell Help Recruited by Glycoconjugate Vaccines
Guttormsen et al.
Infect. Immun. 1999;67:6375-6384.
ABSTRACT | FULL TEXT  

Protein conjugates of synthetic saccharides elicit higher levels of serum IgG lipopolysaccharide antibodies in mice than do those of the O-specific polysaccharide from Shigella dysenteriae type 1
Pozsgay et al.
Proc. Natl. Acad. Sci. USA 1999;96:5194-5197.
ABSTRACT | FULL TEXT  

Repertoire of Human Antibodies against the Polysaccharide Capsule of Streptococcus pneumoniae Serotype 6B
Sun et al.
Infect. Immun. 1999;67:1172-1179.
ABSTRACT | FULL TEXT  

Induction of Immunologic Memory by Conjugated vs Plain Meningococcal C Polysaccharide Vaccine in Toddlers: A Randomized Controlled Trial
MacDonald et al.
JAMA 1998;280:1685-1689.
ABSTRACT | FULL TEXT  

Immunologic Memory Induced by a Glycoconjugate Vaccine in a Murine Adoptive Lymphocyte Transfer Model
Guttormsen et al.
Infect. Immun. 1998;66:2026-2032.
ABSTRACT | FULL TEXT  

Use of Licensed Vaccines for Active Immunization of the Immunocompromised Host
Pirofski and Casadevall
Clin. Microbiol. Rev. 1998;11:1-26.
ABSTRACT | FULL TEXT